Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeru Furuya

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 12, 2015
Potent KCNQ2/3-specific channel activator suppresses in vivo epileptic activity and prevents the development of tinnitusBopanna I Kalappa, Heun Soh, Kevin M Duignan, et al.
Science (New York, N.Y.)|November 5, 2011
A fluoride-derived electrophilic late-stage fluorination reagent for PET imagingEunsung Lee, Adam S Kamlet, David C Powers, et al.
Bioorganic & Medicinal Chemistry|November 7, 2020
N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assayTakeru Furuya, Adam B Shapiro, Janelle Comita-Prevoir, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 12, 2015
Potent KCNQ2/3-specific channel activator suppresses in vivo epileptic activity and prevents the development of tinnitusBopanna I Kalappa, Heun Soh, Kevin M Duignan, et al.
Science (New York, N.Y.)|November 5, 2011
A fluoride-derived electrophilic late-stage fluorination reagent for PET imagingEunsung Lee, Adam S Kamlet, David C Powers, et al.
Bioorganic & Medicinal Chemistry|November 7, 2020
N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assayTakeru Furuya, Adam B Shapiro, Janelle Comita-Prevoir, et al.
Pageof 2